Back
Genmab A/S Quote, Financials, Valuation and Earnings
Sponsored
GMAB
Sponsored
DeFi Coin Triggers All "Buy" Signals And Could Break Out Soon
Discover our top DeFi pick for potentially massive gains now (before it's too late).
Sell
27
GMAB
Genmab A/S
Last Price:
29.72
Seasonality Move:
7.02%
7 Day Trial
ALL ACCESS PASS
$
7
America's Final Republican President
Click here to see his 2024 election prediction.Genmab A/S Price Quote
$29.72
+2.02 (+7.29%)
(Updated: May 3, 2024 at 5:19 PM ET)
Genmab A/S Key Stats
Sell
27
Genmab A/S (GMAB)
is a Sell
Day range:
$27.42 - $28.27
52-week range:
$26.32 - $42.72
Dividend yield:
0%
P/E ratio:
28.90
P/S ratio:
7.63
P/B ratio:
3.85%
Volume:
633.9K
Avg. volume:
443.9K
1-year change:
-32.26%
Market cap:
$18.1B
Revenue:
$2.4B
EPS:
$0.96
How Much Does Genmab A/S Make?
-
How Much Are Genmab A/S's Sales Annually?
GMAB Revenues are $2.4B -
How Much Profit Does Genmab A/S's Make A Year?
GMAB net income is $631.9M
Is Genmab A/S Growing As A Company?
-
What Is Genmab A/S's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.04% -
What Is Genmab A/S's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0.31%
Genmab A/S Stock Price Performance
-
Did Genmab A/S Stock Go Up Last Month?
Genmab A/S share price went down by -7.54% last month -
Did GMAB's Share Price Rise Over The Last Year?
GMAB share price fell by -32.26% over the past 1 year
What Is Genmab A/S 52-Week High & Low?
-
What Is Genmab A/S’s 52-Week High Share Price?
Genmab A/S has traded as high as $42.72 over the past 52 weeks -
What Is Genmab A/S’s 52-Week Low Share Price?
Genmab A/S has traded as low as $26.32 over the past 52 weeks
Genmab A/S Price To Free Cash Flow
-
Is Genmab A/S Stock Overvalued?
Genmab A/S is trading at a price to free cash flow ratio of 17.96 -
Is Genmab A/S Stock Undervalued?
Genmab A/S EV to Free Cash Flow ratio is 13.66 -
What Is Genmab A/S’s Price Earnings Growth Ratio?
GMAB PEG ratio is 0.00 -
Is Genmab A/S Trading At A Premium To Earnings?
Genmab A/S EV to EBIT ratio is 16.84
Is It Risky To Buy Genmab A/S?
-
How Much Debt Does Genmab A/S Have?
Total long term debt quarterly is $0 -
How Much Cash Does Genmab A/S Have?
Cash and short term investments quarterly total is $4.2B -
What Is Genmab A/S’s Book Value Per Share?
Book value per share is 7.18
Is Genmab A/S Cash Flow Positive?
-
What Is GMAB Cash Flow From Operations?
Cash flow from operations (TTM) is $1.1B -
What Is Genmab A/S’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$88M -
What Is Genmab A/S’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$186.1M
Genmab A/S Return On Invested Capital
-
Is Management Doing A Good Job?
GMAB return on invested capital is 14.96% -
What Is Genmab A/S Return On Assets?
ROA measures how assets are converting to revenues and is 13.39% -
What Is GMAB Return On Equity?
ROE is a measure of profitability and is 14.96%
Genmab A/S Earnings Date & Stock Price
-
What Is Genmab A/S's Stock Price Today?
A single share of GMAB can be purchased today for 27.70 -
What Is Genmab A/S’s Stock Symbol?
Genmab A/S trades on the nasdaq under the ticker symbol: GMAB -
When Is Genmab A/S’s Next Earnings Date?
The next quarterly earnings date for Genmab A/S is scheduled on August 1, 2024 -
When Is GMAB's next ex-dividend date?
Genmab A/S's next ex-dividend date is May 3, 2024 -
How To Buy Genmab A/S Stock?
You can buy Genmab A/S shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Genmab A/S Competitors
-
Who Are Genmab A/S's Competitors?
Below is a list of companies who compete with Genmab A/S or are related in some way:
Genmab A/S Dividend Yield
Data Unavailable
Genmab A/S Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 30.82% | -50.06% |
Revenue: | -4.4% | 0.65% |
Analyst Recommendations
Buy Recommendations: | 3 |
---|---|
Hold Recommendations: | 4 |
Sell Recommendations: | 0 |
Price Target: | 39.72 |
Upside from Last Price: | 43.4% |